Condition
High Cholesterol/Hyperlipidemia
Total Trials
5
Recruiting
3
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting3
Active Not Recruiting1
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05526092Not ApplicableActive Not RecruitingPrimary
OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals
NCT06988462Not ApplicableRecruiting
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
NCT06374277Not ApplicableRecruiting
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NCT07220213Not ApplicableRecruiting
FELLAShip to Better Health
NCT05720156Withdrawn
Immunomodulatory Effects of PCSK9 Inhibition
Showing all 5 trials